Based on the complex manifestations of substance P in Alzheimer's disease, this review discusses both protective and damaging mechanisms, and plausible explanations for the double-edged effect of substance P, providing an outlook for future research focusing on substance P and Alzheimer's disease. Here, TAC1 is linked to early-onset autosomal dominant Alzheimer disease.